Work

Primary Prevention Implantable Cardioverter-Defibrillators and Survival in Older Women

Year: 2014

Type: article

Study design: Observational Study

Source: JACC Heart Failure

DOI: 10.1016/j.jchf.2014.09.006

Authors: Emily P. Zeitler, Anne S. Hellkamp, Gregg C. Fonarow, Stephen C. Hammill, Lesley H. Curtis, Adrian F. Hernandez, Hussein R. Al-Khalidi, Jeptha P. Curtis, Paul A. Heidenreich, Kevin J. Anstrom, Eric D. Peterson, Daniel B. Mark, Bradley G. Hammill, Gillian D. Sanders, Sana M. Al-Khatib

Institutions: Duke University, Duke Medical Center, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, Mayo Clinic, Yale University, VA Palo Alto Health Care System

Language: English

Topic: Cardiac pacing and defibrillation studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: American Heart Association, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Ikaria, Boston Scientific Corporation, Medicines Company, Bayer HealthCare, National Institutes of Health, Agency for Healthcare Research and Quality, Abbott Vascular, National Heart, Lung, and Blood Institute

Awards: G1046161961, G2633562640, G3983600346, Postdoctoral Training in Cardiovascular Clinical Research

OpenAlex ID: W2004909941

FWCI: 2.315

Cites: 33

Cited by: 34

Related to: 10